Veracyte: Q2 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Veracyte Inc. (VCYT) on Tuesday reported a loss of $8.4 million in its second quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 12 cents.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.
The molecular diagnostic company posted revenue of $90.3 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $83.9 million.
Veracyte expects full-year revenue in the range of $342 million to $350 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VCYT at https://www.zacks.com/ap/VCYT
